Search

everythinglearnresearchcommunity

for

Search:↓

New compounds were made that effectively block a specific enzyme related to androgen conditions.

Enzalutamide, a prostate cancer drug, may help prevent COVID-19 by blocking the virus from entering lung cells.

The study suggests a possible increase in androgen receptors in patients with frontal fibrosing alopecia, but more research is needed.

Men with higher androgen levels may have severe COVID-19 symptoms, but those on antiandrogen therapy are less likely to contract the virus and have milder symptoms. Anti-androgen drugs could potentially treat COVID-19, but more research is needed.

Male hormones affect oil-producing skin cells differently based on their body location, and the drug spironolactone can reduce these effects.

Dihydrotestosterone causes p27 protein breakdown in ovarian and breast cancer cells by binding with SKP2.

Bisphenol-A (BPA) increases connections between brain cells and boosts their activity, but it blocks the effects of a male hormone on brain cell plasticity.

Prostaglandin D2 increases testosterone production in skin cells through a process involving reactive oxygen species, which could be a new target for treating hair loss and other skin conditions driven by testosterone.

Dihydrotestosterone increases growth and spread of human brain cancer cells, and blocking its formation might help treat this cancer.

New liposome treatment successfully delivers CRISPR to deactivate a key enzyme in androgen-related disorders.

The conclusion is that tritium-labeled testosterone metabolites can be made and are better converted into dihydrotestosterone in skin cells than in prostate tissue.

Antiandrogens might help prevent or treat COVID-19 by blocking the virus's entry into cells.

The document concludes that understanding hair follicle biology can lead to better hair loss treatments.

ADT, especially enzalutamide, may increase the risk of heart rhythm problems and sudden death in men.

Germacrone from Curcuma aeruginosa may help treat conditions related to male hormones by blocking a specific enzyme.

Researchers created five new human scalp cell lines that could be useful for hair growth and loss research.

COVID-19 may affect male fertility and women might have better outcomes due to hormonal and immune differences.

Analog 23 is a promising compound for prostate cancer treatment.

Knowing how skin works and its diseases helps doctors diagnose and treat skin conditions better.

Understanding hair growth involves complex factors, and more research is needed to improve treatments for hair loss conditions.

Hair loss in Androgenetic Alopecia is caused by genetics, aging, and lifestyle, leading to hair follicle shrinkage and related health risks.

New treatments are being explored to slow or reverse hereditary hair loss.

Male pattern hair loss may be linked to the developmental origins of hair follicles.

Flutamide caused damage to male rat reproductive organs and may affect fertility.

The document concludes that accurate diagnosis and treatment are crucial in dermatology, and it presents various findings on skin conditions and treatments.

BLIMP1 is essential for skin maintenance but not for defining sebaceous gland progenitors.

Red Ginseng Extract may help human hair grow by activating growth pathways and blocking negative effects of certain hormones.

Isotretinoin shrinks sebaceous glands without affecting hair or skin color, unlike etretinate.

A gene called BMAL1 plays a role in controlling hair growth.

Male hormones can cause hair loss, but treatments like Minoxidil and Finasteride can help, and targeting TGF-B1 could be a future solution.